Table: begin end state 1 234 cytoplasmic 235 262 transmembrane 263 289 non-cytoplasmic 290 310 transmembrane 311 321 cytoplasmic 322 340 transmembrane 341 373 non-cytoplasmic 374 391 transmembrane 392 419 cytoplasmic 420 441 transmembrane 442 456 non-cytoplasmic 457 482 transmembrane 483 488 cytoplasmic 489 507 transmembrane 508 524 non-cytoplasmic
Input: >WP_086509603.1 NCBI__GCF_002151265.1:WP_086509603.1 MLGLSMTTPAAAQDAAPADDVAAMTLLEALDVDSFPAKGRAIEAIVHSDDPRARDWLQAL LDGRLQRAGDGRFVVVLDNTGRDWPVQDALSGEPLGQMSRRELDRIGINNALRNQLRSAI AVVDLYAADVGLRRASAERLLGEVDGDLAGPLVEVIEEEPDARVRERLVQALAIYRLEQG ELEAIDDLQGSLHPRVRVALNRAANGDDPIVADAAREALNGIEQMLKLNRAAETLYFGLS LGSVLVLAAIGLAITFGVMGVINMAHGELIMLGAYTTWAMQQLLPGQPGLALILAIPAGF LVAALAGIAIERGVIQFLKGRPLETLLATFGISLILQQLVRTGISPLNRTVITPEWMSGS IAVNDALSLTLNRMYVLGFALVVFAVLMLIMRRTRLGLEVRAVTQNRAMARSMGIRATRV DIMTFALGSGVAGLAGVALSQLTNVGPNLGQNYIIDSFMVVVFGGVGNLWGTLVAGLSLG VINQVLEPWAGAVMAKIIVLVFIILFIQKRPRGLFPQKGRAAEG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server